部门组

Cardiovascular

心血管疾病会影响所有年龄段的数百万人。心脏和循环系统的疾病是欧洲死亡的主要原因,也是残疾的主要原因。

医疗技术行业为个人,家庭和更广泛的社会提供了高质量的解决方案。这些创新涵盖了从诊断到治愈的全部患者护理,挽救生命并为欧洲社会增添了巨大价值。

心血管图

What are Cardiovascular Diseases (CVDs)?

心血管疾病(CVD)是心脏和血管疾病组的名称。CVD包括高血压(高血压),冠心病(心脏病发作),脑血管疾病(中风),周围血管疾病,心力衰竭,心脏瓣膜疾病和心肌病。

Source:WHO

CVD为什么是负担?

Cardiovascular diseases are the leading cause of death in Europe and a major cause of disability.

尽早防止,检测和诊断这些状况 - 并在发生时有效地管理它们 - 对于使所有年龄段的公民远离医院和身体健康至关重要,同时有效利用医疗保健资源。

This is why the medical technology industry has aligned to promote a common呼吁采取行动优先考虑欧洲的CVD。

Undescribed image

How medical technologies help to reduce the CVD burden:

High-quality medical technologies are central to Europe’s fight against CVDs and can be found everywhere, e.g. :

  • 鉴定高胆固醇,心脏病发作和心力衰竭患者的血液检查
  • 检测动脉狭窄的现代成像设备
  • 小型心脏植入物,例如起搏器,除颤器和跨科技技术
  • the implantable cardiac monitors and associated home monitoring solutions
  • the minimally-invasive heart valve and stent procedures that improve clinical, procedural and patient outcomes, while reducing associated costs and recurrence


“作为Medtech欧洲心bob多特蒙德app血管部门集团的主席,我期待与当局和利益相关者合作,减轻对医疗保健系统和无数患者的严重影响的心血管疾病负担。”

Medtech Europe的Medtech Chardecular群体集团Jean-Luc Lemerciebob多特蒙德appr

我们认为欧盟可以做的事情:

EU Member States are responsible for the delivery of health and social care to patients. However, they face challenges that could benefit from coordinated action at EU level. There are actions we believe the EU could support to ensure that people live longer, healthier lives and continue to contribute to society:

  1. 更好地了解CVD对社会的影响和负担
  2. 改善患者的生活质量
  3. 通过促进创新来识别其临床和经济价值的技术

We believe strongly that constructive, collaborative partnerships with patients, governments and payers are needed to go even further to help alleviate Europe’s CVD burden once and for all.

博客

Blog

你的心从来都不重要

发表于29.09.2020

Related content